Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114516814B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.